A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain

Peripheral neuropathic pain (PNP) poses a significant clinical challenge. The long-term efficacy of delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray was investigated in this 38-week open-label extension study. In total, 380 patients with PNP associated with diabetes or allodynia...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2015, Vol.262 (1), p.27-40
Hauptverfasser:	Hoggart, B., Ratcliffe, S., Ehler, E., Simpson, K. H., Hovorka, J., Lejčko, J., Taylor, L., Lauder, H., Serpell, M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Analgesics Analgesics - administration & dosage Analgesics - adverse effects Analgesics - pharmacology Cannabidiol Cannabidiol - administration & dosage Cannabidiol - adverse effects Cannabidiol - pharmacology Diabetes Diabetic Neuropathies - complications Dronabinol - administration & dosage Dronabinol - adverse effects Dronabinol - pharmacology Drug Combinations Female Follow-Up Studies Humans Hyperalgesia - complications Male Medicine Medicine & Public Health Middle Aged Nervous system Neuralgia - drug therapy Neuralgia - etiology Neurology Neuroradiology Neurosciences Oral Sprays Original Communication Pain Pain Management Sleep Tetrahydrocannabinol THC Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!